Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRBV26 is a gene segment in the T cell receptor beta locus, classified as a pseudogene in humans. The T cell receptor (TCR) is a protein complex on the surface of T lymphocytes responsible for recognizing peptide antigens presented by major histocompatibility complex (MHC) molecules[1][3]. Each functional TCR is a heterodimer composed of an alpha and a beta chain, both of which are assembled from gene segments (variable, diversity, joining, constant) arranged and recombined during T cell development to generate antigen specificity[1][3][4]. TRBV26 resembles functional TRBV genes but contains sequence changes resulting in a loss of protein-coding potential in humans[3]. In contrast, other TRBV segments contribute to the antigen recognition diversity of the TCR beta chain, which is essential for adaptive immunity[1][4]. As a pseudogene, TRBV26 has no direct biological or therapeutic significance. The broader class to which it belongs, T cell receptor variable gene segments, are critical for immune surveillance, infection defense, and autoimmunity[1]. If you need structured information for a functional TCR variable beta gene, please specify. For the human TRBV26 entry, current databases and expert sources agree this is a pseudogene and not a direct molecular target[3].
Not applicable. No mechanisms of action known for drugs targeting this gene segment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor beta variable 26 (TRBV26).